Background illustration for clinical trials search

Paid Clinical Trials Washington State

Discover 1,593 paid clinical trials in Washington State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

for
Cystic Fibrosis
Location: Boston MA, Worcester MA, New Hyde Park NY, Valhalla NY,
Sponsor: Nicole Hamblett

Sex: All

Age: 12+

Code: NCT06504589

Recruiting

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

for
Generalized Myasthenia Gravis (gMG)
Location: Boston MA, Worcester MA, New York NY, Rochester NY,
Sponsor: Cabaletta Bio

Sex: All

Age: 18 - 70

Code: NCT06359041

Phase1, Phase2, Recruiting

DALY II USA/ MB-CART2019.1 for DLBCL

for
Refractory Diffuse Large B Cell Lymphoma (DLBCL),
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: Miltenyi Biomedicine GmbH

Sex: All

Age: 18+

Code: NCT04792489

Phase2, Recruiting

TVMR With the INNOVALVE System Trial - Early Feasibility Study

for
Mitral Valve Regurgitation (Degenerative or Functional)
Location: Manhasset NY, Morristown NJ, Philadelphia PA, Naples FL,
Sponsor: Edwards Lifesciences

Sex: All

Age: 18+

Code: NCT04919980

Recruiting

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

for
Urothelial Carcinoma
Location: Worcester MA, Commack NY, Uniondale NY, Harrison NY,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT04879329

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

for
Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma,
Location: Peabody MA, Burlington MA, Commack NY, Uniondale NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03866382

Phase2, Recruiting

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

for
NonSegmental Vitiligo
Location: St. John's, Halifax, Boston MA, Quebec, Woodbury NY,
Sponsor: Incyte Corporation

Sex: All

Age: 2 - 11

Code: NCT06548360

Phase3, Recruiting

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

for
Acute Lymphoblastic Leukemia in Remission,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT03670966

Phase1, Phase2, Recruiting

MAGIC Ruxolitinib for aGVHD

for
Acute Graft-versus-host Disease,
Location: Boston MA, New York NY, Atlanta GA, Nashville TN,
Sponsor: John Levine

Sex: All

Age: 18+

Code: NCT06936566

Phase2, Recruiting

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Sydney, Boston MA, Quebec, Massapequa NY, The Bronx NY,
Sponsor: AstraZeneca

Sex: All

Age: 40 - 70+

Code: NCT06283966

Phase3, Recruiting

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

for
Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma
Location: Raleigh NC, Durham NC, Jacksonville FL, Danville IL,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT05647265

Phase2, Recruiting

Rare and Atypical Diabetes Network

for
Diabetes Mellitus, Diabetes Mellitus Progression,
Location: Boston MA, Brooklyn NY, New York NY, Baltimore MD,
Sponsor: University of South Florida

Sex: All

Age: 0+

Code: NCT05544266

Recruiting

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: New Haven CT, Quebec, New Brunswick NJ, Montreal,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136650

Phase3, Recruiting

Popular cities in Washington State

SpokaneBellinghamSeattleKentEverettTacomaRenton